Relay Therapeutics
RLAY
RLAY
157 hedge funds and large institutions have $2.16B invested in Relay Therapeutics in 2023 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 50 increasing their positions, 50 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
157
Holders Change
-8
Holders Change %
-4.85%
% of All Funds
2.51%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.08%
New
25
Increased
50
Reduced
50
Closed
32
Calls
$5.12M
Puts
$4.35M
Net Calls
+$769K
Net Calls Change
-$925K
Top Buyers
| 1 |
CC
Casdin Capital
New York
|
+$43.9M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$39M |
| 3 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$20.2M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$10.8M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$4.68M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$29.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.3M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
-$12.4M |
| 4 |
Millennium Management
New York
|
-$8.59M |
| 5 |
State Street
Boston,
Massachusetts
|
-$6.33M |
